by ADRIAN FREDERICK MANZ Manz | Jan 22, 2026 | The Doctor's Dose
Intel Stock Pulls Back Near 4-Year High Ahead of Earnings Shares of INTC paused on Thursday after a powerful rally pushed the stock to its highest levels since early 2022. While the pullback may look like hesitation on the surface, the broader price action suggests...
by ADRIAN FREDERICK MANZ Manz | Jan 21, 2026 | The Doctor's Dose
Markets Rebound as Trade Tensions Ease Wall Street staged a broad relief rally today as stocks and bonds climbed after :contentReference[oaicite:0]{index=0} walked back his latest tariff threats toward Europe. The sudden shift eased fears of a fast-moving...
by ADRIAN FREDERICK MANZ Manz | Jan 16, 2026 | The Doctor's Dose
Why Nvidia’s Stock Isn’t Partying Like Other Parts of the Chip Sector This Year The strange setup: strong AI signals, weaker relative performance Nvidia shares moved higher following strong semiconductor earnings and bullish AI-related guidance — yet they still lagged...
by ADRIAN FREDERICK MANZ Manz | Jan 15, 2026 | The Doctor's Dose
Verizon Gets Final California Approval for Frontier Deal — Intraday Trading Implications Verizon (VZ) received final approval from California regulators to acquire Frontier Communications (FYBR), clearing the last major state hurdle for its $9.6B deal (valued around...
by ADRIAN FREDERICK MANZ Manz | Jan 13, 2026 | The Doctor's Dose
Trump’s Iran Tariff Threat: What It Means for Markets and Traders President Donald Trump escalated tensions with Iran this week by announcing that any country doing business with the Islamic Republic would face a 25 percent tariff on trade with the United States,...
by ADRIAN FREDERICK MANZ Manz | Jan 7, 2026 | The Doctor's Dose
Train the Body, Strengthen the Mind: How Exercise Builds Trading Discipline Trading is a performance discipline. If you want steadier execution, better emotional control, and cleaner decision-making, you can’t only train your charts — you have to train your body too....
by ADRIAN FREDERICK MANZ Manz | Jan 7, 2026 | The Doctor's Dose
Why Intel’s Stock Surged as the AI Trade Broadened — and What Traders Should Watch Next Intel surprised the market by jumping to the top of the S&P 500 leaderboard as the AI narrative broadened beyond the usual “GPU-only” winners. For traders, this wasn’t just a...
by ADRIAN FREDERICK MANZ Manz | Jan 6, 2026 | The Doctor's Dose
Boredom in Trading: Why Doing Nothing Is One of the Hardest (and Most Profitable) Skills One of the least discussed — yet most destructive — forces in active trading is boredom in trading psychology. Not fear. Not greed. Boredom. Sitting in front of a screen, watching...
by ADRIAN FREDERICK MANZ Manz | Jan 6, 2026 | The Doctor's Dose
Nvidia’s “Tremendous” AI Demand Message: What Traders Should Watch as Vera Rubin Heads Toward Launch Nvidia didn’t need an earnings surprise to move the conversation this week. At CES, the company reinforced a simple narrative: Demand for AI and accelerated computing...
by ADRIAN FREDERICK MANZ Manz | Jan 6, 2026 | The Doctor's Dose
Plan the Trade. Trade the Plan. Why Discipline Is the Real Edge (ATI Case Study) One of the biggest advantages in markets isn’t a new indicator, a faster feed, or a better opinion. It’s trading discipline and execution—the ability to follow your plan to the letter...
